Research Options:
Select below
IPO Calendar
Week of Expected Pricing
Withdrawn
Company Name
SANCILIO PHARMACEUTICALS COMPANY, INC
Proposed Ticker
N/A
CUSIP
79971N108
Business Description
An integrated specialty pharmaceutical company focused on developing and, in the future, commercializing products based on our proprietary Advanced Lipid Technologies, or ALT, platform
Lead Underwriter
Piper Jaffray & Co.,UBS Investment Bank
Co-Managers
FBR Capital Markets & Co,JMP Securities LLC
Initial Shares
N/A
Revised Initial Shares
N/A
Initial Price
N/A
Revised Price
N/A
Final Price
N/A
Final Ticker
N/A
© 2024 ICE Data Services. All rights reserved.
